EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. A

Multiresidue determination of fluoroquinolones in poultry muscle and kidney according to the regulation 2002/657/EC. A systematic comparison of two different approaches: Liquid chromatography coupled to high-resolution mass spectrometry or tandem mass spectrometry.


PMID 25577647

Abstract

This work involved the optimization and validation of two methods according to the Commission Decision 2002/657/EC directives for determining fluoroquinolones residues in samples of poultry muscle and kidney: ciprofloxacin, danofloxacin, difloxacin, enrofloxacin, flumequine, marbofloxacin, nalidixic acid, norfloxacin, ofloxacin, oxolinic acid, pipemidic acid and sarafloxacin. The extraction procedure was based on a QuEChERS approach, whose optimization employed a Box-Behnken 3(3) factorial design. A liquid chromatography-tandem mass spectrometry method (LC-MS/MS) was developed for determining the twelve analytes using the multiple reaction monitoring mode (MRM). Accuracy, evaluated by recovery studies, varied from 88.8 to 112.2% for the selected levels with RSD values lower than 12.3%. The second validated method employed high resolution mass spectrometry (HRMS) performed in the single ion monitoring mode (SIM), determining nine among twelve analytes. The validation parameters were evaluated as satisfactory, with recoveries from 82.5 to 114.4% and RSD lower than 8.7%. Decision limits and detection capabilities for both methods were reported. The two methods were statistically compared using the Student's t test, at 95% confidence level, resulting in no significant difference.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D2757
2,3-Diaminonaphthalene, ≥95% (HPLC), powder
C10H10N2
88461
2,3-Diaminonaphthalene, BioReagent, suitable for fluorescence, ≥98.0% (HPLC)
C10H10N2
33700
Danofloxacin, VETRANAL, analytical standard
C19H20FN3O3
17849
Enrofloxacin, ≥98.0% (HPLC)
C19H22FN3O3
33699
Enrofloxacin, VETRANAL, analytical standard
C19H22FN3O3
Y0001259
Enrofloxacin, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
1235900
Enrofloxacin, United States Pharmacopeia (USP) Reference Standard
C19H22FN3O3
PHR1513
Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
C19H22FN3O3
Y0001160
Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
34039
Marbofloxacin, VETRANAL, analytical standard
C17H19FN4O4
Y0000819
Marbofloxacin, European Pharmacopoeia (EP) Reference Standard
C17H19FN4O4
Y0000820
Marbofloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard
C17H19FN4O4
N8878
Nalidixic acid, ≥98%
C12H12N2O3
N5035
Nalidixic acid, meets USP testing specifications
C12H12N2O3
1451000
Nalidixic acid, United States Pharmacopeia (USP) Reference Standard
C12H12N2O3
97023
Nalidixic acid, analytical standard
C12H12N2O3
N0050000
Nalidixic acid, European Pharmacopoeia (EP) Reference Standard
C12H12N2O3
N9890
Norfloxacin, analytical standard, ≥98% (TLC)
C16H18FN3O3
33899
Norfloxacin, VETRANAL, analytical standard
C16H18FN3O3
N1230000
Norfloxacin, European Pharmacopoeia (EP) Reference Standard
C16H18FN3O3
Y0001301
Norfloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard
C16H18FN3O3
Y0001015
Norfloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
C16H18FN3O3
O8757
Ofloxacin, fluoroquinolone antibiotic
C18H20FN3O4
33703
Ofloxacin, VETRANAL, analytical standard
C18H20FN3O4
1478108
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
C18H20FN3O4
PHR1168 Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
C18H20FN3O4
O0877
Oxolinic acid, quinolone antibiotic
C13H11NO5
67126
Oxolinic acid, analytical standard
C13H11NO5
O0240000
Oxolinic acid, European Pharmacopoeia (EP) Reference Standard
C13H11NO5
P7903
Pipemidic acid
C14H17N5O3